Compare PLETHICO PHARMA with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA J.B.CHEMICALS PLETHICO PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x -1.1 15.6 - View Chart
P/BV x 0.0 2.1 0.8% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 PLETHICO PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
J.B.CHEMICALS
Mar-18
PLETHICO PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs395363 108.8%   
Low Rs31255 12.3%   
Sales per share (Unadj.) Rs604.4169.1 357.3%  
Earnings per share (Unadj.) Rs32.516.6 195.7%  
Cash flow per share (Unadj.) Rs51.323.4 219.2%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs473.6172.5 274.5%  
Shares outstanding (eoy) m34.0883.57 40.8%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.41.8 19.3%   
Avg P/E ratio x6.618.6 35.2%  
P/CF ratio (eoy) x4.213.2 31.5%  
Price / Book Value ratio x0.51.8 25.1%  
Dividend payout %012.0 0.0%   
Avg Mkt Cap Rs m7,26225,827 28.1%   
No. of employees `000NA3.8 0.0%   
Total wages/salary Rs m1,5962,511 63.6%   
Avg. sales/employee Rs ThNM3,747.4-  
Avg. wages/employee Rs ThNM665.7-  
Avg. net profit/employee Rs ThNM367.8-  
INCOME DATA
Net Sales Rs m20,59814,135 145.7%  
Other income Rs m386366 105.6%   
Total revenues Rs m20,98414,501 144.7%   
Gross profit Rs m2,8182,178 129.4%  
Depreciation Rs m642570 112.7%   
Interest Rs m1,59335 4,565.0%   
Profit before tax Rs m9691,940 49.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138552 -25.1%   
Profit after tax Rs m1,1071,387 79.8%  
Gross profit margin %13.715.4 88.8%  
Effective tax rate %-14.328.5 -50.2%   
Net profit margin %5.49.8 54.8%  
BALANCE SHEET DATA
Current assets Rs m18,87710,470 180.3%   
Current liabilities Rs m11,8962,749 432.8%   
Net working cap to sales %33.954.6 62.0%  
Current ratio x1.63.8 41.7%  
Inventory Days Days3655 65.1%  
Debtors Days Days19878 254.7%  
Net fixed assets Rs m9,8615,811 169.7%   
Share capital Rs m341167 203.9%   
"Free" reserves Rs m12,33114,248 86.5%   
Net worth Rs m16,13914,416 112.0%   
Long term debt Rs m4,7060-   
Total assets Rs m33,14617,649 187.8%  
Interest coverage x1.656.6 2.8%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.60.8 77.6%   
Return on assets %8.18.1 101.1%  
Return on equity %6.99.6 71.3%  
Return on capital %12.313.7 89.7%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Exports (fob) Rs m4,402NA-   
Imports (cif) Rs m3,136NA-   
Fx inflow Rs m4,4026,164 71.4%   
Fx outflow Rs m3,1841,334 238.6%   
Net fx Rs m1,2194,829 25.2%   
CASH FLOW
From Operations Rs m2,4371,231 198.1%  
From Investments Rs m-6,265-208 3,010.4%  
From Financial Activity Rs m2,490-595 -418.4%  
Net Cashflow Rs m-1,337427 -313.1%  

Share Holding

Indian Promoters % 82.7 55.4 149.3%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 4.3 3.4 126.8%  
FIIs % 5.5 3.9 141.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 37.0 20.3%  
Shareholders   10,665 30,437 35.0%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   GLENMARK PHARMA  UNICHEM LAB  DR. REDDYS LAB  DIVIS LABORATORIES  ALEMBIC LTD  

Compare PLETHICO PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - STERLING BIOTECH COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS